Newsletter Signup | Join Community
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are part of recurrent NSCLC treatment.
Local ablative treatment combined with immunotherapy improves long term survival in oligometastatic NSCLC.
Tagrissio, Tarceva and other TKI therapy for EGFR + NSCLC continue to evolve and improve survival.
Avastin can be effectively combined with chemotherapy, immunotherapy, and tyrosine kinase inhibitors to treat NSCLC.
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are used to treat stage IIIB-IV NSCLC.
Patients With NSCLC Are Not Undergoing Biomarker Testing for Precision Medicines-Patient Education is Key
Research suggests that tumor mutational burden assessment can help predict response to immunotherapy in NSCLC.
Tarceva™ Improves Survival in Non-Small Cell Lung Cancer
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended but…
HER 2 + Lung Cancer Treatment? https://coloradocancerblogs…
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to…
High incidence of ROS 1 false negative tests reported by U Colorado researchers. http://www…